(Q40938926)

25 September 2017

1 reference

title

Expanding indications for the use of Class III agents in patients at high risk for sudden death (English)

1 reference

25 September 2017

Singh BN

1

1 reference

25 September 2017

publication date

1 October 1995

1 reference

Journal of Cardiovascular Electrophysiology

25 September 2017

published in

1 reference

25 September 2017

volume

6

1 reference

25 September 2017

issue

10 Pt 2

1 reference

25 September 2017

page(s)

887-900

1 reference

Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials.

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1995.TB00365.X

Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1995.TB00365.X

Randomized study of implantable defibrillator as first-choice therapy versus conventional strategy in postinfarct sudden death survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1995.TB00365.X

Channel specificity in antiarrhythmic drug action. Mechanism of potassium channel block and its role in suppressing and aggravating cardiac arrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1995.TB00365.X

The historical development, cellular electrophysiology and pharmacology of amiodarone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1995.TB00365.X

Arrhythmia control by prolonging repolarization: the concept and its potential therapeutic impact

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1995.TB00365.X

Choice and chance in drug therapy of cardiac arrhythmias: technique versus drug-specific responses in evaluation of efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1995.TB00365.X

Amiodarone-associated proarrhythmic effects. A review with special reference to torsade de pointes tachycardia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1995.TB00365.X

Amiodarone and post-MI patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1995.TB00365.X

The European Myocardial Infarct Amiodarone Trial (EMIAT). EMIAT Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1995.TB00365.X

Arrhythmias in ischemic and nonischemic dilated cardiomyopathy: prediction of mortality by ambulatory electrocardiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1995.TB00365.X

Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1995.TB00365.X

A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS Investigators and Committees

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1995.TB00365.X

10.1111/J.1540-8167.1995.TB00365.X

21 January 2018

Identifiers

DOI

1 reference

25 September 2017

1 reference